Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ATIS is on the move! -- Ignore unavailable to you. Want to Upgrade?

To: Harry D. Kramer who wrote (1290)	1/16/1998 12:30:00 AM
From: Bruce Long	Read Replies (1) \| Respond to of 2205

Harry, Do you know why the shorts do not believe that ATIS may not be able to capture a significant market share? Is it because they have doubts that S&N will be able to effectively bring the product to market, or because of questions with the product(Dermagraft)? I agree with you that it's suprising that the price movement seems to be going with the brakes on, but I suspect it is not because of the product or the relationship with S&N; but rather just a matter of the current market environment. A year ago when the market was much lower, around 6000+, ATIS was up near 20 with news of poss FDA approval. Marshall mentioned a few posts back that it seems the market for ATIS is much more skeptical the second time around-not surprising. To me this means more realistic valuation of the stock, and possibly less price volatility. I would rather see a price increase with good news rather then sell on the news that seems to be the history with ATIS. As for the shorts, I don't see why they would be scared at this point. I suspect that even after FDA approval, they still have time to cover even if the price reaches 15-18 and still get a good return going long. Regardless, I think any of us that have been holding ATIS would be crazy to get cold feet now. Would love to hear more about your views on S&N. Regards, Bruce Long